Abstract
It is established that the gut microbiota has a significant influence on Alzheimer’s disease. In turn, both the disease and the microbiota are affected by biological variables associated with modern lifestyles. Examination of the potential interrelationship among these three factors and on the role played by lifestyles in gut dysbiosis-induced pathologies of Alzheimer’s disease are limited. Deciphering these connections will provide insights into the pathogenesis and therapeutic strategies for Alzheimer’s disease. Specifically, based on this trilateral relationship, various nonpharmacological interventive strategies targeting the gut microbiota can be developed. This review fills this gap by presenting the latest evidence for the modulative role of modern lifestyle on the gut microbiota and its relevance to Alzheimer’s disease, with a discussion on the limitations of current research and future directions.
Keywords: Gut microbiota, Alzheimer's disease, modern lifestyle, dietary pattern, exercise, mental stress.
Graphical Abstract
Current Aging Science
Title:Gut Microbiota as a Link between Modern Lifestyle and Alzheimer’s Disease
Volume: 14 Issue: 3
Author(s): Yi Wang*Gary Dykes
Affiliation:
- School of Agriculture and Food Sciences, University of Queensland, Keyhole Road, St Lucia, Queensland 4067,Australia
Keywords: Gut microbiota, Alzheimer's disease, modern lifestyle, dietary pattern, exercise, mental stress.
Abstract: It is established that the gut microbiota has a significant influence on Alzheimer’s disease. In turn, both the disease and the microbiota are affected by biological variables associated with modern lifestyles. Examination of the potential interrelationship among these three factors and on the role played by lifestyles in gut dysbiosis-induced pathologies of Alzheimer’s disease are limited. Deciphering these connections will provide insights into the pathogenesis and therapeutic strategies for Alzheimer’s disease. Specifically, based on this trilateral relationship, various nonpharmacological interventive strategies targeting the gut microbiota can be developed. This review fills this gap by presenting the latest evidence for the modulative role of modern lifestyle on the gut microbiota and its relevance to Alzheimer’s disease, with a discussion on the limitations of current research and future directions.
Export Options
About this article
Cite this article as:
Wang Yi *, Dykes Gary , Gut Microbiota as a Link between Modern Lifestyle and Alzheimer’s Disease, Current Aging Science 2021; 14 (3) . https://dx.doi.org/10.2174/1874609814666210609100048
DOI https://dx.doi.org/10.2174/1874609814666210609100048 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification
Current Pharmaceutical Design Evidence For A Functional Contribution of Adenosine Signalling in Inflammatory Airway Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Aging as an Evolvability-Increasing Program Which can be Switched Off by Organism to Mobilize Additional Resources for Survival
Current Aging Science miR-126 as a Therapeutic Agent for Diabetes Mellitus
Current Pharmaceutical Design Is there an Association Between Periodontitis and Atherosclerosis in Adults? A Systematic Review
Current Vascular Pharmacology Progress in the Rational Design for Polypharmacology Drug
Current Pharmaceutical Design Immunomodulation in Polytrauma and Polymicrobial Sepsis - Where Do We Stand?
Recent Patents on Inflammation & Allergy Drug Discovery Role of C-Reactive Protein in Acute Myocardial Infarction and Stroke: Possible Therapeutic Approaches
Current Pharmaceutical Biotechnology Recent U.S. Patents on Protein Drug Formulation: 2000-2007
Recent Patents on Drug Delivery & Formulation COVID-19 Pandemic and the Impact on the Cardiovascular Disease Patient Care
Current Cardiology Reviews Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry Molecular Docking, DFT Studies and ADMET Simulations for Evaluating Already Approved FDA Drugs as Inhibitors for SARS-Cov-2 RNADependent Polymerase
Letters in Drug Design & Discovery Subject Index to Volume 5
Current Protein & Peptide Science Biological Ageing, Inflammation and Nutrition: How Might They Impact on Systemic Sclerosis?
Current Aging Science Tacrolimus Toxicity Reverses the Inhibitory Effects of Renin Angiotensin System Blockade on PAI-1 Expression in Cardiac Tissue
Current Enzyme Inhibition Therapeutic Hypothermia for Cardiopulmonary Resuscitation: Why, When and How
Current Cardiology Reviews Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
Current Vascular Pharmacology Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology Inhibitors of the Chemokine Receptor CXCR4: Chemotherapy of AIDS, Metastatic Cancer, Leukemia and Rheumatoid Arthritis
Letters in Drug Design & Discovery TNF as a Target of Inflammation in Rheumatoid Arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets